Which British company is a partner in the India Genomics Centre of Excellence inaugurated in New Delhi?

The correct answer is the eighth edition. The Council met in New Delhi with Dr Jitendra Singh, Union Minister of State with Independent Charge for Science and Technology and Earth Sciences, on the Indian side and Jonathan Reynolds, the British Secretary of State for Business, Innovation and Trade, on the other. The meeting reviewed progress in bilateral science and innovation work and discussed stronger research partnerships, cooperation in emerging technologies and the translation of research into practical applications. On the same occasion the two ministers opened a genomics centre of excellence in the capital. Options A, B and D give the sixth, seventh and ninth editions, none of which matches this meeting. Aspirants should record the edition number along with the venue and the two ministers, because questions on bilateral councils almost always hinge on the serial number of the sitting.

The correct answer is the Department of Science and Technology with Innovate UK. This collaboration supports joint industrial research and development aimed at creating new intellectual property, technologies, processes and prototypes, and eight projects have been agreed for support in areas including advanced manufacturing, power electronics and net-zero technologies. They are at various stages of implementation. Option B wrongly pairs the Anusandhan National Research Foundation, whose Chief Executive Officer was part of the Indian delegation, with a British research body. Option C names the Technology Development Board, whose Secretary also attended, with a cultural organisation, which is not the partnership described. Option D is similarly incorrect. Aspirants should remember the pairing of the department with Innovate UK and the three technology areas named with it.

The correct answer is the India-UK Green Hydrogen Compact, which is not among the frameworks named. Cooperation under the Council rests on three instruments: the India-UK Research and Innovation Memorandum of Understanding in option A, the Technology Security Initiative in option B, and India-UK Vision 2035 in option C. These provide the foundation on which research institutions, universities, industry and innovators work together, with attention to scientific advance and to turning research into technologies and applications. The agenda spans artificial intelligence, quantum technologies, semiconductors, critical minerals, advanced materials, biotechnology, telecommunications and net-zero technologies, and joint research also covers antimicrobial resistance, healthcare, agriculture, weather and climate science and geohazards. Candidates should memorise the three framework names together, as a question may ask for the odd one out.

The correct answer is Technology Readiness Level 4 and above. Eligible Technology Enterprises working at that level or higher can receive capital channelled by the Second Level Fund Managers, which means the fund steps in once an idea has moved past paper and early concept work and has been validated in a laboratory setting. Option A would include the earliest conceptual stages, which the fund is not designed for; option C would restrict support to technologies close to full deployment, by which point commercial money is usually easier to find; and option D is wrong because the whole purpose of the fund is to support work before a product reaches the market. The design addresses a financing gap that has long limited private investment in emerging and strategic technologies, and managers must raise private capital matching the fund's own contribution.

The correct answer is the Anusandhan National Research Foundation, which works under the Department of Science and Technology in the Ministry of Science and Technology. The fund is run by an Independent Business Unit housed within that foundation, and the foundation's Executive Council is one of the stages a fund manager's proposal must clear before it reaches the Empowered Group of Secretaries. Option A is wrong because NITI Aayog advises on policy and does not manage investment funds of this kind. Option B names the country's largest chain of research laboratories, which conducts research rather than channelling patient capital to enterprises. Option D is a development finance institution for small industry, a plausible-sounding home for a fund but not the one chosen here. The first call for applications from prospective managers went out in January 2026.